Sanofi’s Alpha-1 Antitrypsin Deficiency (AATD) Thought Leader Liaison (TLL) is a field-based commercial role that leverages data to identify and profile customers, coordinates HCP peer-to-peer and patient programming, and gathers insights across customer groups to inform commercial strategy and execution.
Base: $146,250.00 - $211,250.00; Bonus/Equity: Eligible for STI only (pre-launch), IC eligible (at launch); Benefits: Not specified
Must-have
Nice-to-have
Not specified